Leucovorin Calcium: Clinical Trials

432 trials of Leucovorin Calcium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

275 completed, 50 terminated, 44 unknown, 28 active not recruiting. 221 Phase 2, 124 Phase 3, 90 Phase 1, 20 Not applicable, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2221Completed 133, Terminated 31, Unknown 24, Active not recruiting 13, Withdrawn 11, Recruiting 8, Not yet recruiting 1
Phase 3124Completed 74, Unknown 19, Active not recruiting 14, Terminated 12, Recruiting 4, Not yet recruiting 1
Phase 190Completed 66, Active not recruiting 6, Recruiting 5, Terminated 5, Withdrawn 5, Unknown 2, Not yet recruiting 1
Not applicable20Completed 14, Terminated 2, Unknown 2, Withdrawn 2
Phase 43Completed 1, Recruiting 1, Suspended 1
Early Phase 12Completed 2

Follow Leucovorin Calcium: new trials by email Literature Review of Leucovorin Calcium trials Research Report on Leucovorin Calcium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma
ONO-4578, Placebo, Nivolumab - Gastric Cancer, Esophagogastric Junction Cancer
Phase 3Not yet recruitingOno Pharmaceutical Co., Ltd.6002027-02-012026-09-14
Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
Biospecimen Collection, Computed Tomography, Fluorouracil - Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Phase 1Not yet recruitingCity of Hope Medical Center302026-12-012026-09-02
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2Not yet recruitingSWOG Cancer Research Network902026-10-142026-10-13
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer
Biospecimen Collection, Computed Tomography, Dynamic Contrast-Enhanced Magnetic Resonance Imaging - Borderline Resectable Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingOhio State University Comprehensive Cancer Center502026-10-012026-10-05
Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma
Phase 3RecruitingCity of Hope Medical Center1292026-10-012026-09-25
A Placebo-controlled Trial of Folinic Acid in Children With ASD
Folinic Acid, Placebo - Autism Spectrum Disorder
Phase 2RecruitingProf. Adi Aran1502026-06-232026-06-22
NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial
Biospecimen Collection, Computed Tomography, Fluorouracil - Borderline Resectable Pancreatic Ductal Adenocarcinoma
Phase 2RecruitingRoswell Park Cancer Institute202026-03-022026-09-21
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8
Phase 1 / Phase 2RecruitingRoswell Park Cancer Institute352026-02-162026-08-19
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Biopsy Procedure, Biospecimen Collection, Capecitabine - Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3RecruitingNRG Oncology3562025-08-212026-08-25
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8
Phase 1RecruitingNational Cancer Institute (NCI)242025-06-232026-09-09
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
Balstilimab, Biospecimen Collection, Botensilimab - Rectal Adenocarcinoma, Stage IIA Rectal Cancer AJCC v8
Phase 2RecruitingCity of Hope Medical Center262025-05-202026-06-29
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Myelodysplastic Syndrome
Phase 1RecruitingChildren's Oncology Group362025-02-042026-08-25
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.
PF-07985045, Gemcitabine, Nab-paclitaxel - Carcinoma, Pancreatic Ductal, Colorectal Neoplasms
Phase 1TerminatedPfizer302024-12-102026-05-22
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
PF-07934040, Gemcitabine, Nab-paclitaxel - Carcinoma, Pancreatic Ductal, Colorectal Neoplasms
Phase 1Active not recruitingPfizer642024-06-272026-10-13
Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)
Binimetinib, Biopsy Procedure, Biospecimen Collection - Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)172024-02-092026-10-19
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
Atezolizumab, Biospecimen Collection, Capecitabine - Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2Active not recruitingNational Cancer Institute (NCI)22023-12-062026-07-01
Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis
Aldesleukin, Biopsy Procedure, Biospecimen Collection - Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma
Phase 1Active not recruitingMayo Clinic152023-11-292026-07-01
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
Biospecimen Collection, Computed Tomography, Endoscopic Ultrasound - Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2RecruitingMayo Clinic992023-11-212026-10-01
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer
Balstilimab, Bevacizumab, Biospecimen Collection - Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma
Phase 1 / Phase 2Active not recruitingCity of Hope Medical Center202023-05-032026-09-01
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Biospecimen Collection, Computed Tomography, Core Biopsy - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingJonsson Comprehensive Cancer Center562023-03-072026-05-22

Showing 20 of 432. Sign in to see all of them.

Conditions studied

Colonic Neoplasms (149)  ·  Colorectal Neoplasms (149)  ·  Rectal Neoplasms (147)  ·  Lymphoma (41)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (40)  ·  Leukemia (34)  ·  Stomach Neoplasms (32)  ·  Pancreatic Neoplasms (31)  ·  Burkitt Lymphoma (28)  ·  Neoplasm Metastasis (26)  ·  Adenocarcinoma Of Esophagus (22)  ·  HIV Infections (22)  ·  Acquired Immunodeficiency Syndrome (21)  ·  Esophageal Neoplasms (20)  ·  Lymphoma, Non-Hodgkin (13)

Sponsors

National Cancer Institute (NCI) (63)  ·  Children's Oncology Group (27)  ·  Alliance for Clinical Trials in Oncology (24)  ·  Memorial Sloan Kettering Cancer Center (20)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (16)  ·  City of Hope Medical Center (14)  ·  European Organisation for Research and Treatment of Cancer - EORTC (14)  ·  SWOG Cancer Research Network (13)  ·  GERCOR - Multidisciplinary Oncology Cooperative Group (11)  ·  Federation Francophone de Cancerologie Digestive (10)  ·  UNICANCER (8)  ·  Eastern Cooperative Oncology Group (7)  ·  Mayo Clinic (7)  ·  Medical Research Council (7)  ·  Roswell Park Cancer Institute (7)

Countries

United States (314)  ·  Canada (59)  ·  France (52)  ·  Puerto Rico (40)  ·  Australia (31)  ·  United Kingdom (29)  ·  Switzerland (25)  ·  Germany (24)  ·  Italy (23)  ·  Belgium (19)  ·  Netherlands (19)  ·  New Zealand (14)  ·  Austria (12)  ·  Portugal (8)  ·  Sweden (8)

Top investigators

Feinberg J (5)  ·  Leonard B. Saltz, MD (5)  ·  Marwan Fakih (5)  ·  Henry C. Pitot, MD (4)  ·  Nancy E. Kemeny, MD (4)  ·  Tanya Trippett, MD (4)  ·  Aimery de Gramont, MD (3)  ·  Al B. Benson, MD, FACP (3)  ·  Bach Ardalan, MD (3)  ·  Claus-Henning Koehne, MD (3)  ·  Heinz-Josef Lenz (3)  ·  Howard S. Hochster, MD (3)  ·  Luft B (3)  ·  Michel Ducreux, MD, PhD (3)  ·  Steven R. Alberts, MD (3)

Results publications

PMID 31268130, PMID 21997132, PMID 33356421, PMID 37890117, PMID 39121442, PMID 23007406, PMID 23233662, PMID 26590194, PMID 28006055, PMID 29284596, PMID 31811950, PMID 32085892, PMID 33242441, PMID 36306483, PMID 36603187, PMID 38315963, PMID 38446568, PMID 40315406, PMID 41671463, PMID 42085640, PMID 10442378, PMID 10499612, PMID 10550154, PMID 11098486, PMID 11426549, PMID 11600602, PMID 11913730, PMID 12047964, PMID 12204666, PMID 12239143, PMID 12782596, PMID 12860947, PMID 12963697, PMID 14665611, PMID 15042678, PMID 15353542, PMID 15470715, PMID 15558814, PMID 15637138, PMID 15646530, PMID 15659500, PMID 15677624, PMID 15774775, PMID 15939923, PMID 16009951, PMID 16009952, PMID 16009958, PMID 16105981, PMID 16110021, PMID 16230673

NIH funding

U10CA098543 (19), U10CA031946 (14), U10CA180886 (14), U10CA032102 (13), P30CA033572 (8), U10CA021115 (8), U10CA180821 (7), U10CA180820 (6), U10CA180888 (6), P30CA015083 (5), U10CA012027 (5), P30CA008748 (4), P30CA014089 (4), P30CA016672 (4), P30CA036727 (4)